A new article in AIDS and Behavior examines the impact of COVID-19 on syringe services programs (SSPs) in the U.S. The findings are based on the results of a survey distributed to SSPs by the North American Syringe Exchange Network and key informant interviews conducted with SSPs in COVID-19 hot spots. One-fourth reported closing at least one site and nearly half of SSPs report a decrease in the availability of services, including medication for opioid use disorder and HIV, hepatitis C, and STI testing. More than half are prepacking all supplies for clients, 20% are providing delivery services, and 6% are providing mail-based services.
The Impact of COVID-19 on Syringe Services Programs in the United States
May 06, 2020 | Kim Rodgers
Related Posts
- Community Engagement
- Community Resilience
- Emergency Response
- Maternal, Child, & Adolescent Health
Preparedness Month Profile: An Interview with Sue...
To celebrate Preparedness Month, NACCHO is highlighting Western Upper Peninsula...
Sep 27, 2022 | Elana Filipos, Gideon Amaniel
Preparedness Month Profile: An Interview with Sue...
- Community Engagement
- Emergency Response
- Maternal, Child, & Adolescent Health
Preparedness Month Profile: An Interview with Allison...
To celebrate Preparedness Month, NACCHO is highlighting Jefferson County...
Sep 27, 2022 | Elana Filipos, Gideon Amaniel
Preparedness Month Profile: An Interview with Allison...
- Tools & Resources
- Antibiotic Resistance
- Healthy Living & Prevention
- Infectious Disease
September is Sepsis Awareness Month: Learn How You Can...
September is Sepsis Awareness Month and CDC encourages its partners, patients,...
Sep 07, 2022 | Jaclyn Abramson
September is Sepsis Awareness Month: Learn How You Can...
- COVID-19
- Immunization
- Infectious Disease
- Community Health
Doing Homework on Vaccines this Back-to-School Season?...
With a new school year beginning, this is a reminder that routine vaccines are...
Sep 01, 2022 | Guest Blogger Kaye Hayes, Deputy Assistant Secretary for Infectious Disease and the Director of the Office of Infectious Disease and HIV/AIDS Policy, U.S. Department of Health and Human Services